Current HER2 Testing Recommendations and Clinical Relevance as a Predictor of Response to Targeted Therapy

标题
Current HER2 Testing Recommendations and Clinical Relevance as a Predictor of Response to Targeted Therapy
作者
关键词
Breast cancer, Fluorescence in situ hybridization, Human epidermal growth factor receptor 2, Immunohistochemistry, Trastuzumab
出版物
Clinical Breast Cancer
Volume 15, Issue 3, Pages 171-180
出版商
Elsevier BV
发表日期
2014-12-02
DOI
10.1016/j.clbc.2014.11.009

向作者/读者发起求助以获取更多资源

Reprint

联系作者

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started